Ameritas Advisory Services’s Strata Critical Medical Inc Warrants SRTAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-8,500
Closed -$4.08K 763
2023
Q1
$4.08K Buy
+8,500
New +$5.25K ﹤0.01% 2211

Other funds holding SRTAW

Ameritas Advisory Services's SRTAW Position: Q2 2023 in Review

Ameritas Advisory Services sold out of Strata Critical Medical Inc Warrants (SRTAW) in Q2 2023, closing a stake of 8,500 shares — an estimated $4.08K sold.

Ameritas Advisory Services first reported a position in SRTAW in Q1 2023 and held it in 1 quarter. The position peaked at $4.08K in Q1 2023. 10 funds tracked by Wall St. Rank hold SRTAW as of Q2 2023.

  • Ameritas Advisory Services reported no remaining Strata Critical Medical Inc Warrants position as of Q2 2023 after selling out during the quarter.
  • Ameritas Advisory Services sold 8,500 Strata Critical Medical Inc Warrants shares in Q2 2023, an estimated $4.08K.
  • Ameritas Advisory Services first reported a position in Strata Critical Medical Inc Warrants in Q1 2023 and held it in 1 quarter.
  • Ameritas Advisory Services's Strata Critical Medical Inc Warrants position peaked at $4.08K in Q1 2023.
  • 10 funds tracked by Wall St. Rank held Strata Critical Medical Inc Warrants as of Q2 2023.

Based on Ameritas Advisory Services's 13F filing for Q2 2023, filed 25 Jul 2023.